Comparative processing and function of human and ferret cystic fibrosis transmembrane conductance regulator

Journal of Biological Chemistry

Volumn 287, Issue 26, 2012, Pages 21673-21685

  Fisher, John T ^a   Liu, Xiaoming ^a   Yan, Ziying ^a   Luo, Meihui ^a   Zhang, Yulong ^a   Zhou, Weihong ^a   Lee, Ben J ^a   Song, Yi ^a   Guo, Chenhong ^b   Wang, Yujiong ^b   Lukacs, Gergely L ^c   Engelhardt, John F ^a  

^a UNIVERSITY OF IOWA   (United States)

^b NINGXIA UNIVERSITY   (China)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; APICAL MEMBRANES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATORS; GENE MUTATIONS; HETEROLOGOUS EXPRESSION; HT-1080; LOW LEVEL; MEMBRANE STABILITY; PROTEIN PROCESSING; PROTEIN STABILITY; WESTERN BLOTS;

CELLS; CHLORINE COMPOUNDS; CYTOLOGY; GENES; STABILITY;

PROTEINS;

CYCLIC AMP; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL CELL; ARTICLE; CELL STRAIN; CELL STRAIN BHK; CELL STRAIN COS7; CELL STRAIN CUFI; CELL STRAIN HEK293; CELL STRAIN HT1080; CELL SURFACE; CHLORIDE CURRENT; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTIC FIBROSIS; FERRET; GOLGI COMPLEX; HUMAN; HUMAN CELL; MATURATION; MEMBRANE STABILIZATION; NONHUMAN; ORTHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STABILITY; RESPIRATORY EPITHELIUM; WESTERN BLOTTING; WILD TYPE;

ANIMALS; CELL LINE; CELL MEMBRANE; CHLORIDES; COS CELLS; CRICETINAE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FERRETS; GLYCOSYLATION; GOLGI APPARATUS; HEK293 CELLS; HUMANS; MUTATION; PERMEABILITY; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS; SPECIES SPECIFICITY;

EID: 84862648349     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.336537     Document Type: Article

References (34)

1. Rosenstein, B. J., and Zeitlin, P. L. (1998) Cystic fibrosis. Lancet 351, 277-282
2. Rowe, S. M., Miller, S., and Sorscher, E. J. (2005) Cystic fibrosis. N. Engl. J. Med. 352, 1992-2001
3. Egan, M. E. (2009) How useful are cystic fibrosis mouse models? Drug Discov. Today 6, 35-41
4. Fisher, J. T., Zhang, Y., and Engelhardt, J. F. (2011) Comparative biology of cystic fibrosis animal models. Methods Mol. Biol. 742, 311-334
5. Grubb, B. R., and Boucher, R. C. (1999) Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol. Rev. 79, S193-S214
6. Stoltz, D. A., Meyerholz, D. K., Pezzulo, A. A., Ramachandran, S., Rogan, M. P., Davis, G. J., Hanfland, R. A., Wohlford-Lenane, C., Dohrn, C. L., Bartlett, J. A., Nelson, G. A., 4th, Chang, E. H., Taft, P. J., Ludwig, P. S., Estin, M., Hornick, E. E., Launspach, J. L., Samuel, M., Rokhlina, T., Karp, P. H., Ostedgaard, L. S., Uc, A., Starner, T. D., Horswill, A. R., Brogden, K. A., Prather, R. S., Richter, S. S., Shilyansky, J., McCray, P. B., Jr., Zabner, J., and Welsh, M. J. (2010) Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci. Transl. Med. 2, 29ra31
7. Sun, X., Sui, H., Fisher, J. T., Yan, Z., Liu, X., Cho, H. J., Joo, N. S., Zhang, Y., Zhou, W., Yi, Y., Kinyon, J. M., Lei-Butters, D. C., Griffin, M. A., Naumann, P., Luo, M., Ascher, J., Wang, K., Frana, T., Wine, J. J., Meyerholz, D. K., and Engelhardt, J. F. (2010) Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. J. Clin. Invest. 120, 3149-3160
8. Ostedgaard, L. S., Meyerholz, D. K., Chen, J. H., Pezzulo, A. A., Karp, P. H., Rokhlina, T., Ernst, S. E., Hanfland, R. A., Reznikov, L. R., Ludwig, P. S., Rogan, M. P., Davis, G. J., Dohrn, C. L., Wohlford-Lenane, C., Taft, P. J., Rector, M. V., Hornick, E., Nassar, B. S., Samuel, M., Zhang, Y., Richter, S. S., Uc, A., Shilyansky, J., Prather, R. S., McCray, P. B., Jr., Zabner, J., Welsh, M. J., and Stoltz, D. A. (2011) The ΔF508 mutation causes CFTR misprocessing and cystic fibrosis-like disease in pigs. Sci. Transl. Med. 3, 74ra24
9. Rogers, C. S., Stoltz, D. A., Meyerholz, D. K., Ostedgaard, L. S., Rokhlina, T., Taft, P. J., Rogan, M. P., Pezzulo, A. A., Karp, P. H., Itani, O. A., Kabel, A. C., Wohlford-Lenane, C. L., Davis, G. J., Hanfland, R. A., Smith, T. L., Samuel, M., Wax, D., Murphy, C. N., Rieke, A., Whitworth, K., Uc, A., Starner, T. D., Brogden, K. A., Shilyansky, J., McCray, P. B., Jr., Zabner, J., Prather, R. S., and Welsh, M. J. (2008) Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321, 1837-1841
10. Drumm, M. L., Pope, H. A., Cliff, W. H., Rommens, J. M., Marvin, S. A., Tsui, L. C., Collins, F. S., Frizzell, R. A., and Wilson, J. M. (1990) Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell 62, 1227-1233
11. Gregory, R. J., Cheng, S. H., Rich, D. P., Marshall, J., Paul, S., Hehir, K., Ostedgaard, L., Klinger, K. W., Welsh, M. J., and Smith, A. E. (1990) Expression and characterization of the cystic fibrosis transmembrane conductance regulator. Nature 347, 382-386
12. Riordan, J. R. (1993) The cystic fibrosis transmembrane conductance regulator. Annu. Rev. Physiol. 55, 609-630
13. Riordan, J. R., Rommens, J. M., Kerem, B., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., and Chou, J. L. (1989) Identification of the cystic fibrosis gene. Cloning and characterization of complementary DNA. Science 245, 1066-1073
14. Bradbury, N. A., Cohn, J. A., Venglarik, C. J., and Bridges, R. J. (1994) Biochemical and biophysical identification of cystic fibrosis transmembrane conductance regulator chloride channels as components of endocytic clathrin-coated vesicles. J. Biol. Chem. 269, 8296-8302
15. Prince, L. S., Workman, R. B., Jr., and Marchase, R. B. (1994) Rapid endocytosis of the cystic fibrosis transmembrane conductance regulator chloride channel. Proc. Natl. Acad. Sci. U.S.A. 91, 5192-5196
16. Sharma, M., Pampinella, F., Nemes, C., Benharouga, M., So, J., Du, K., Bache, K. G., Papsin, B., Zerangue, N., Stenmark, H., and Lukacs, G. L. (2004) Misfolding diverts CFTR from recycling to degradation. Quality control at early endosomes. J. Cell Biol. 164, 923-933
17. Chang, X. B., Mengos, A., Hou, Y. X., Cui, L., Jensen, T. J., Aleksandrov, A., Riordan, J. R., and Gentzsch, M. (2008) Role of N-linked oligosaccharides in the biosynthetic processing of the cystic fibrosis membrane conductance regulator. J. Cell Sci. 121, 2814-2823
18. Cheng, S. H., Gregory, R. J., Marshall, J., Paul, S., Souza, D. W., White, G. A., O'Riordan, C. R., and Smith, A. E. (1990) Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63, 827-834
19. Glozman, R., Okiyoneda, T., Mulvihill, C. M., Rini, J. M., Barriere, H., and Lukacs, G. L. (2009) N-Glycans are direct determinants of CFTR folding and stability in secretory and endocytic membrane traffic. J. Cell Biol. 184, 847-862
20. Farinha, C. M., Mendes, F., Roxo-Rosa, M., Penque, D., and Amaral, M. D. (2004) A comparison of 14 antibodies for the biochemical detection of the cystic fibrosis transmembrane conductance regulator protein. Mol. Cell Probes 18, 235-242
21. Amaral, M. D. (2004) CFTR and chaperones. Processing and degradation. J. Mol. Neurosci. 23, 41-48
22. Kerem, B., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., and Tsui, L. C. (1989) Identification of the cystic fibrosis gene. Genetic analysis. Science 245, 1073-1080
23. Zielenski, J., and Tsui, L. C. (1995) Cystic fibrosis. Genotypic and phenotypic variations. Annu. Rev. Genet. 29, 777-807
24. Lukacs, G. L., Mohamed, A., Kartner, N., Chang, X. B., Riordan, J. R., and Grinstein, S. (1994) Conformational maturation of CFTR but not its mutant counterpart (ΔF508) occurs in the endoplasmic reticulum and requires ATP. EMBO J. 13, 6076-6086
25. Sharma, M., Benharouga, M., Hu, W., and Lukacs, G. L. (2001) Conformational and temperature-sensitive stability defects of the ΔF508 cystic fibrosis transmembrane conductance regulator in post-endoplasmic reticulum compartments. J. Biol. Chem. 276, 8942-8950
26. Skach, W. R. (2000) Defects in processing and trafficking of the cystic fibrosis transmembrane conductance regulator. Kidney Int. 57, 825-831
27. Ward, C. L., and Kopito, R. R. (1994) Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins. J. Biol. Chem. 269, 25710-25718
28. Lukacs, G. L., Chang, X. B., Bear, C., Kartner, N., Mohamed, A., Riordan, J. R., and Grinstein, S. (1993) The ΔF508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells. J. Biol. Chem. 268, 21592-21598
29. Dalemans, W., Barbry, P., Champigny, G., Jallat, S., Dott, K., Dreyer, D., Crystal, R. G., Pavirani, A., Lecocq, J. P., and Lazdunski, M. (1991) Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation. Nature 354, 526-528
30. Ostedgaard, L. S., Rogers, C. S., Dong, Q., Randak, C. O., Vermeer, D. W., Rokhlina, T., Karp, P. H., and Welsh, M. J. (2007) Processing and function of CFTR-ΔF508 are species-dependent. Proc. Natl. Acad. Sci. U.S.A. 104, 15370-15375
31. Liu, X., Luo, M., Zhang, L., Ding, W., Yan, Z., and Engelhardt, J. F. (2007) Bioelectric properties of chloride channels in human, pig, ferret, and mouse airway epithelia. Am. J. Respir. Cell Mol. Biol. 36, 313-323
32. Liu, Y., Wang, Y., Jiang, Y., Zhu, N., Liang, H., Xu, L., Feng, X., Yang, H., and Ma, T. (2008) Mild processing defect of porcine ΔF508-CFTR suggests that ΔF508 pigs may not develop cystic fibrosis disease. Biochem. Biophys. Res. Commun. 373, 113-118
33. Zabner, J., Karp, P., Seiler, M., Phillips, S. L., Mitchell, C. J., Saavedra, M., Welsh, M., and Klingelhutz, A. J. (2003) Development of cystic fibrosis and noncystic fibrosis airway cell lines. Am. J. Physiol. Lung Cell Mol. Physiol. 284, L844-L854
34. Pedemonte, N., Lukacs, G. L., Du, K., Caci, E., Zegarra-Moran, O., Galietta, L. J., and Verkman, A. S. (2005) Small-molecule correctors of defective ΔF508-CFTR cellular processing identified by high-throughput screening. J. Clin. Investig. 115, 2564-2571